Combined therapy in untreated patients improves outcome in Nasal NK/T lymphoma: results of a clinical trial

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 614 citations · Full text

Medicine, Oncology, Cancer Immunology +12

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 602 citations

Pharmacy, Oncology, Pharmacotherapy +13

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

Arnaud Jaccard, Nathalie Gachard, Benôıt Marin et al. · Blood · 2010 · 386 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

Chor Sang Chim, Shing-yan Ma, Wing‐Yan Au et al. · Blood · 2003 · 380 citations · Full text

Medicine, Oncology, Otolaryngology +10

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Seok Jin Kim, Byung‐Soo Kim, Chul Yong Kim et al. · Journal of Clinical Oncology · 2009 · 341 citations · Full text

Medicine, Oncology, Radiation Oncology +15